The pathogenesis of tuberculosis

Annual Review of Microbiology

Volumn 50, Issue , 1996, Pages 259-284

  Rook, G A W ^a   Hernandez Pando, Rogelio ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

adrenal; cytokine profiles; immunopathology; tumor necrosis factor

Indexed keywords

BCG VACCINATION; IMMUNITY; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTION SENSITIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CYTOKINES; GLUCOCORTICOIDS; HUMANS; IMMUNITY, CELLULAR; MICE; MODELS, IMMUNOLOGICAL; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM; MYCOBACTERIUM BORIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 0029840797     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.50.1.259     Document Type: Review

References (120)

1. Anderson MC. 1891. On Koch's treatment. Lancet 1:651-52
2. Averill L, Toossi Z, Aung H, Boom WH, Ellner JJ. 1995. Regulation of production of tumor necrosis factor alpha in monocytes stimulated by the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 63:3206-8
3. Balasubramanian R, Sivasubramanian S, Vijayan VK, Ramachandran R, Jawahar MS, et al. 1990. Five year results of a 3 month and two 5 month regimens for the treatment of sputum-positive pulmonary tuberculosis in South India. Tubercle 71:253-58
4. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. 1990. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J. Immunol. 145:149-54
5. Barnes PF, Grisso CL, Abrams JS, Band H, Rea TH, Modlin RL. 1992. Gamma delta T lymphocytes in human tuberculosis. J. Infect. Dis. 165:506-12
6. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. 1993. Cytokine production at the site of disease in tuberculosis. Infect. Immun. 61:3482-89
7. + T cells. Nature 372:691-94
8. Bertini R, Bianchi M, Ghezzi P. 1988. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167:1708-12
9. Blauer KL, Poth M, Rogers WM, Bernton EW. 1991. Dehydroepiandrosterone antagonises the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129(6):3174-79
10. Bordet P. 1931. Contribution l'étude de l'allergie. C. R. Soc. Biol. 107:622-23
11. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-42
12. Brincourt J. 1967. Le calciférol a-t-il une action liquéfiante sur le caseum? Poumon Coeur 23:841-51
13. Brown DH, LaFuse W, Zwilling BS. 1995. Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Beg gene (candidate Nramp). Infect. Immun. 63:2983-88
14. Cadranel J, Garabedian M, Milleron B, Guillozo H, Akoun G, Hance AJ. 1990. 1,25(OH)2 D3 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcaemic patients with tuberculosis. J. Clin. Invest. 85:1588-93
15. Carswell EA, Old LJ, Kassel RL, Green S, Fiore W, Williamson B. 1975. An endotoxin-induced serum factor that causes necrosis of tumours. Proc. Natl. Acad. Sci. USA 72:3666-70
16. Chan J, Fan X, Hunter SW, Brennan PJ, Bloom BR. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-61
17. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-40
18. Chan J, Xing Y, Magliozzo RS, Bloom BR. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-22
19. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177-80
20. Clerici M, Shearer GM. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-81
21. Cohen IR, Young DB. 1991. Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 12:105-10
22. Constant P, Davodeau F, Peyrat M, Poquet Y, Puzo G, et al. 1994. Stimulation of human g/d T cells by nonpeptidic mycobacterial ligands. Science 264:267-70
23. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-47
24. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-32
25. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-42
26. Daynes RA, Araneo BA, Hennebold J, Enioutina E, Mu HH. 1994. Steroids as essential regulators of the mammalian immune response. J. Invest. Dermatol. 105:S15-S19
27. Daynes RA, Meikle AW, Araneo BA. 1991. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res. Immunol. 142:40-45
28. Debonera G, Tzortakis N, Falchetti E. 1932. Inflammation et phénomene de Shwartzman. C. R. Soc. Biol. 109:24-26
29. Dougherty TF, Berliner ML, Berliner DL. 1960. 11b-hydroxy dehydrogenase system activity in thymi of mice following prolonged cortisol treatment. Endocrinology 66:550-58
30. Etemadi A, Farid R, Stanford JL. 1992. Immunotherapy for drug-resistant tuberculosis. Lancet 340:1360-61
31. Ferluga J, Doenhoff MJ, Allison AC. 1979. Increased hepatofoxicity of bacterial lipopolysaccharide in mice infected with Schistosoma mansoni. Parasite Immunol. 1:289-94
32. Filley EA, Bull HA, Dowd PM, Rook GAW. 1992. The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of Tumour Necrosis Factor. Immunology 77:505-9
33. Filley EA, Rook GAW. 1991. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Infect. Immun. 59:2567-72
34. Fine PEM. 1993. Immunities in and to tuberculosis: implications for pathogenesis and vaccination. In Tuberculosis: Back to the Future. Proc. London Sch. Hyg. Trop. Med. 3rd Annu. Public Health Forum, ed. KPWJ McAdam, JDH Porter, pp. 54-78. Chichester, England: Wiley
35. Fine PEM, Ponnighaus JM, Maine N, Clarkson JA, Bliss L. 1986. The protective efficacy of BCG against leprosy in Northern Malawi. Lancet 2:499-502
36. Fine PEM, Sterne JAC, Ponnighaus JM, Rees RJW. 1994. Delayed type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 344:1245-49
37. Fischer A, Konig W. 1991. Influence of cytokines and cellular interactions on the glucocorticoid-induced Ig (E, G, A, M) synthesis of peripheral blood mononuclear cells. Immunology 74:228-33
38. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-54
39. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-72
40. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89:12013-17
41. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-24
42. Follows GA, Munk ME, Gatrill AJ, Conradt P, Kaufmann SH. 1992. Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma/delta T-cell cultures after activation with bacteria. Infect. Immun. 60:1229-31
43. Gibbs JH, Grange JM, Beck JS, Jawad E, Potts RC, et al. 1991. Early delayed hypersensitivity responses in tuberculin sidn tests after heavy occupational exposure to tuberculosis. J. Clin. Pathol. 44:919-23
44. Grange JM. 1992. The mystery of the mycobacterial persister. Tubercle Lung Dis. 73:249-51
45. Grzych JM, Pearce E, Cheever A, Caulada ZA, Caspar P, et al. 1991. Egg deposition is the stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146:1322-40
46. Hawken M, Nunn P, Gathua S, Brindle R, Godfrey-Faussett P, et al. 1993. Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya. Lancet 342:332-37
47. Hernandez-Pando R, Orozco H, Honour JP, Silva J, Leyva R, Rook GAW. 1995. Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis? FEMS Immunol. Med. Microbiol. 12:63-72
48. Hernandez-Pando R, Rook GAW. 1994. The role of TNFa in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology 82:591-95
49. Hilkens CM, Vermeulen H, van-Neerven RJ, Snijdewint FG, Wierenga EA, Kapsenberg ML. 1995. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25:59-63
50. Hirsch CS, Ellner JJ, Russell DG, Rich EA. 1994. Complement receptor mediated uptake and Tumour Necrosis Factor a-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-53
51. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, et al. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N. Engl. J. Med. 330:1348-55
52. Horwitz MA, Lee BW, Dillon BJ, Harth G. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92:1530-34
53. Ilangumaran S, Ami S, Poincelet M, Theler JM, Brennan PJ, et al. 1995. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 155:1334-42
54. Ityavyar DA. 1988. Health service inequalities in Nigeria. Soc. Sci. Med. 27:1223-35
55. Kabelitz D, Bender A, Schondelmaier S, Schoel B, Kaufmann SH. 1990. A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein. J. Exp. Med. 171:667-79
56. Kaleab B, OttenoffT, Converse P, Halapi E, Tadesse G, et al. 1990. Mycobacterial-induced cytotoxic T cells as well as non-specific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 20:2651-59
57. Kaplan G. 1994. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology 191:564-68
58. Kardjito T, Beck JS, Grange JM, Stanford JL. 1986. A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects. Eur. J. Respir. Dis. 69:142-45
59. Kaufmann SH, Blum C, Yamamoto S. 1993. Crosstalk between alpha/beta T cells and gamma/delta T cells in vivo: activation of alpha/beta T-cell responses after gamma/delta T-cell modulation with the monoclonal antibody GL3. Proc. Natl. Acad. Sci. USA 90:9620-24
60. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-40
61. Koch R. 1891. Fortsetzung über ein Heilmittel gegen Tuberculose. Dtsch. Med. Wochenschr. 17:101-2
62. Kumararatne DS, Drysdale P, Gaston JS, Stacey P, Richardson P, Wise R. 1988. Mycobacterium tuberculosis antigen specific human T-cell lines are cytolytic to autologous antigen pulsed macrophages. Adv. Exp. Med. Biol. 237:401-6
63. Ladel CH, Daugelat S, Kaufmann SH. 1995. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and Il-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25:377-84
64. Ladel CH, Hess J, Daugelat S, Mombaerts P, Tonegawa S, Kaufmann SH. 1995. Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor-deficient mutant mice. Eur. J. Immunol. 25:838-46
65. Lemire JM. 1994. Immunomodulatory actions of 1,25-dihydroxy vitamin D3. J. Steroid. Biochem. Mol. Biol. 53:599-602
66. Macassey L, Saleeby CW. 1934. Spahlinger Contra Tuberculosis 1908-1934. An International Tribute. London: Bale /Danielsson. 271 pp.
67. Macrae DE. 1947. Calciferol treatment of Lupus vulgaris. Br. Med. J. 59:333-38
68. McDonough KA, Kress Y, Bloom BR. 1993. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:2763-73
69. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. 1993. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177:1675-80
70. Moreno C, Taverne J, Mehlert A, Bate CA, Brealey RJ, et al. 1989. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of Tumour Necrosis Factor from human and murine macrophages. Clin. Exp. Immunol. 76:240-45
71. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-57
72. Munk ME, Gatrill AJ, Schoel B, Gulle H, Pfeffer K, et al. 1990. Immunity to mycobacteria: possible role of alpha/beta and gamma/delta T lymphocytes. Acta Pathol. Microbiol. Immunol. Scand. Sect. A 98:669-73
73. Myrvik QN, Leake ES, Wright MJ. 1984. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. Am. Rev. Respir. Dis. 129:322-28
74. Nagao S, Tanaka A. 1985. Necrotic inflammatory reaction induced by muramyl dipeptide in guinea-pigs sensitized by tubercle bacilli. J. Exp. Med. 162:401-12
75. Onwubalili JK, Scott GM, Smith H. 1986. Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. Q. J. Med. 59:599-610
76. Onyebujoh PC, Abdulmumini T, Robinson S, Rook GAW, Stanford JL. 1995. Immunotherapy for tuberculosis in African conditions. Resp. Med. 89:199-207
77. Orme IM, Miller ES, Roberts AD, Furney SK, Griffin JP, et al. 1992. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 148:189-96
78. Orme IM, Roberts AD, Griffin JP, Abrams JS. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518-25
79. Panchamoorthy G, McLean J, Modlin RL, Morita CT, Ishikawa S, et al. 1991. A predominance of the T cell receptor V gamma 2/V delta 2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J. Immunol. 147:3360-69
80. + T cells of mycobacteria growing in human macrophages. Science 260:984-86
81. Post FA, Soule SG, Willcox PA, Levitt NS. 1994. The spectrum of endocrine dysfunction in active pulmonary tuberculosis. Clin. Endocrinol. 40:367-71
82. Rigby WF, Yirinec B, Oldershaw RL, Fanger MW. 1987. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur. J. Immunol. 17:563-66
83. Roach TIA, Chatterjee D, Blackwell JM. 1994. Induction of early-response genes KC and JE by mycobactenal lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect. Immun. 62:1176-84
84. Rook GAW. 1988. The role of vitamin D in tuberculosis. Am. Rev. Respir. Dis. 138:768-70
85. Rook GAW, Hernandez-Pando R, Lightman SL. 1994. Hormones, peripherally activated prohormones, and regulation of the TH1/TH2 balance. Immunol. Today 15:301-3
86. 85a. Rook GAW, Honour J, Kon OM, Wilkinson RJ, Davidson R, Shaw RJ. 1996. Urinary steroid metabolites in tuberculosis; a new clue to pathogenesis. Q. J. Med. 88:333-41
87. Rook GAW, Onyebujoh P, Stanford JL. 1993. TH1→TH2 switch and loss of CD4 cells in chronic infections; an immuno-endocrinological hypothesis not exclusive to HIV. Immunol. Today 14:568-69
88. Rook GAW, Steele J, Ainsworth M, Champion BR. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333-38
89. Rook GAW, Steele J, Fraher L, Barker S, Karmali R, et al. 1986. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159-63
90. Rook GAW, Taverne J, Leveton C, Steele J. 1987. The role of gamma-interferon, vitamin D3 metabolites and tumor necrosis factor in the pathogenesis of tuberculosis. Immunology 62:229-34
91. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, et al. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-82
92. Sarma GR, Chandra I, Ramachandran G, Krishnamurthy PV, Kumaraswami V, Prabhakar R. 1990. Adrenocortical function in patients with pulmonary tuberculosis. Tubercle 71:277-82
93. Schauf V, Rom WN, Smith KA, Sampaio EP, Meyn PA, et al. 1993. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J. Infect. Dis. 168:1056-59
94. Scott GM, Murphy PG, Gemidjioglu ME. 1990. Predicting deterioration of treated tuberculosis by corticosteroid reserve and C-reactive protein. J. Infect. 21:61-69
95. Shands JW, Senterfitt VC. 1972. Endotoxin-induced hepatic damage in BCG-infected mice. Am. J. Pathol. 67:23-40
96. Shwartzman G. 1937. Phenomenon of Local Tissue Reactivity and its Immunological, Pathological, and Clinical Significance. New York: Hoeber. 461 pp.
97. Siegele DA, Kolter R. 1992. Life after log. J. Bacteriol. 174:345-48
98. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, et al. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227-30
99. Silva CL, Lowrie DB. 1994. A single mycobacterial protein (hsp65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology 82:244-48
100. Silver RF, Wallis RS, Ellner JJ. 1995. Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals. J. Immunol. 154:4665-74
101. Singhal M, Banavalikar JN, Sharma S, Saha K. 1989. Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy. Tubercle 70:171-78
102. Spahlinger H. 1922. Note on the treatment of tuberculosis. Lancet 1:5-8
103. Spence DP, Hotchkiss J, Williams CS, Davies PD. 1993. Tuberculosis and poverty. Br. Med. J. 307:759-61
104. Stanford JL, Grange JM. 1994. The promise of immunotherapy for tuberculosis. Respir. Med. 88:3-7
105. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, et al. 1994. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263:678-81
106. Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, et al. 1994. Th1/Th2 profiles in tuberculosis based on proliferation and cytokine response of peripheral blood lymphocytes to mycobacterial antigens. Immunology 81:171-76
107. Swanson-Beck J, Potts RC, Kardjito T, Grange JM. 1985. T4 lymphopenia in patients with active pulmonary tuberculosis. Clin. Exp. Immunol. 60:49-54
108. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. 1995. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375:155-58
109. Tobach E, Bloch H. 1956. Effect of stress by crowding prior to and following tuberculous infection. Am. J. Physiol. 187:399-402
110. van-der-Pouw-Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181:775-79
111. Veyron P, Pamphile R, Binderup L, Touraine JL. 1993. Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice. Transpl. Immunol. 1:72-76
112. Vidai S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, et al. 1995. The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nrampl gene. J. Exp. Med. 182:655-66
113. 111a. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, et al. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc. Natl. Acad. Sci. USA 92:7804-8
114. Wilson GS, Schwabacher H, Maier I. 1940. The effect of the desensitization of tuberculous guinea-pigs. J. Pathol. Bacteriol. 50:89-109
115. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, et al. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376:594-96
116. Xu S, Cooper A, Sturgill-Koszycki S, van Heyningen T, Chatterjee D, et al. 1994. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J. Immunol 153:2568-78
117. Yong AJ, Grange JM, Tee RD, Beck JS, Bothamley GH, et al. 1989. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. Tubercle 70:273-79
118. Young DB. 1992. Heat-shock proteins: immunity and autoimmunity. Curr. Opin. Immunol. 4:396-400
119. Zack MB, Fulkerson LL, Stein E. 1973. Glucose intolerance in pulmonary tuberculosis. Am. Rev. Respir. Dis. 108:1164-69
120. Zuckerman SH, Shellhaas J, Butler LD. 1989. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis; effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur. J. Immunol. 19:301-5